系别:必赢唯一官方网站
电话:-
邮箱:zhouhj9@mail.sysu.edu.cn
- 研究方向
统计推断;决策论;统计预测;生物统计;大数据分析
- 研究成果
Dissertation
Zhou, Haojin. "The Equivariance Criterion in Statistical Prediction and Its Ramifications." PhD diss., The George Washington University, 2011.
Consider predicting an unobserved random variable Y based on the observed value of a
random vector X, under an assumed model. In this context, we formalize the basic logic of
equivariance to serve it as a useful tool for selecting a predictor. The development involves a
new framework and more intricate transformation groups, compared to those involved in a
standard decision problem. We establish the structure and many interesting properties of the
transformation groups. Conditions for the existence of equivariant predictors, construction of
all equivariant predictors and determination of a uniformly minimum risk equivariant
predictor are described in terms of maximal invariants and orbits. The theoretical results are
applied to location, scale and location-scale models and illustrated with several examples.
Publication List
1. Zhou, Haojin, and Tapan K. Nayak."Pitman closest equivariant estimators and predictors under location–scale models."Journal of Statistical Planning and Inference 142, no. 6 (2012): 1367-1377.
2. Rothmann, Mark, Kallappa Koti, Kyung Yul Lee, Hong Laura Lu, Yuan Li Shen, Jenny J. Zhang, Mei Jin, and Haojin Zhou."Evaluating and Adjusting for Premature Censoring of Progression-Free Survival."Journal of biopharmaceutical statistics 23, no. 5 (2013): 1091-1105.
3. Halabi, Susan, William Kevin Kelly, Haojin Zhou, Andrew J. Armstrong, David Quinn, Karim Fizazi, Nicole C. Solomon et al. "The site of visceral metastases (mets) to predict overall survival (OS) in castration-resistant prostate cancer (CRPC) patients (pts): A meta-analysis of five phase III trials." (2014): 5002-5002.
4. Zhou, Haojin, and Tapan K. Nayak. "A note on existence and construction of invariant loss functions." Statistics 48, no. 6 (2014): 1335-1343.
5. Zhou, Haojin, and Tapan K. Nayak."On the equivariance criterion in statistical prediction."Annals of the Institute of Statistical Mathematics 67, no. 3 (2015): 541-555..
6. Halabi, Susan, William Kevin Kelly, Hua Ma, Haojin Zhou, Nicole C. Solomon, Karim Fizazi, Catherine M. Tangen et al."Meta-analysis evaluating the impact of site of metastasis on overall survival in men with castration-resistant prostate cancer."J Clin Oncol 34, no. 14 (2016): 1652-1659.
7. Lauring, Brett, Sam S. Miller, Tania Krumins, Hao Jin Zhou, Susan Huyck, Jeremy Johnson, Gregory Golm, Steven G. Terra, James P. Mancuso, and Samuel S. Engel. "Safety and efficacy of ertugliflozin in combination with sitagliptin in subjects with T2DM inadequately controlled on diet and exercise: the VERTIS SITA Trial." In DIABETES, vol. 66, pp. A319-A320. 1701 N BEAUREGARD ST, ALEXANDRIA, VA 22311-1717 USA: AMER DIABETES ASSOC, 2017.
8. Ivete Maldonado; Manuel Plata; Mauricio Gonzalez; Alfonso Correa; Claudia Noss; Hao Jin Zhou; Amita Joshi, PhD; Das Rita; Alfred Saah; Ulrike Kirsten Buchwald (2017). A 10 YEAR FOLLOW-UP OBSERVATION OF THE SAFETY, IMMUNOGENICITY, AND EFFECTIVENESS OF THE QUADRIVALENT HPV VACCINE (GARDASIL™) IN MID-ADULT WOMEN—THE FUTURE III STUDY. PLoS Medicine. (Accepted)
9. Miller, Sam, Tania Krumins, Haojin Zhou, Susan Huyck, Jeremy Johnson, Gregory Golm, Steven G. Terra, James P. Mancuso, Samuel S. Engel, and Brett Lauring. "Ertugliflozin and Sitagliptin Co-initiation in Patients with Type 2 Diabetes: The VERTIS SITA Randomized Study." Diabetes Therapy (2018): 1-16.
- 学习经历
2002.9-2006.7 南开大学必赢唯一官方网站 概率论与数理统计专业 理学学士学位
2006.9-2011.8 美国乔治华盛顿大学 数理统计专业 博士
- 工作经历
2011.10-2013.7 美国俄亥俄州立大学化学工程与生物分子系 博士后研究员
2013.8-2014.8 美国杜克大学生物统计和生物信息系 博士后研究员
2015.1-2018.4 默沙东研发(中国)有限公司 资深统计师